Therefore, the authors concluded that the different PLOD isoenzymes possess non-overlapping functionality in ovarian cancer with unexpected impact on gene regulation networks in addition to their direct enzymatic roles in hydroxylation and glycosylation of target proteins (Guo et al., 2021). Here, PLOD1 is linked to ovarian cancer.